<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Protein O-linked <z:chebi fb="0" ids="37684">mannose</z:chebi> beta1,2-N-acetylglucosaminyltransferase 1 (POMGnT1) catalyzes the transfer of GlcNAc to O-<z:chebi fb="0" ids="37684">mannose</z:chebi> of <z:chebi fb="0" ids="17089">glycoproteins</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>Mutations in the POMGnT1 gene cause a type of <z:hpo ids='HP_0003741'>congenital muscular dystrophy</z:hpo> called muscle-eye-<z:e sem="disease" ids="C0006111" disease_type="Disease or Syndrome" abbrv="">brain disease</z:e> (MEB) </plain></SENT>
<SENT sid="2" pm="."><plain>We evaluated several truncated mutants of POMGnT1 to determine the minimal catalytic domain </plain></SENT>
<SENT sid="3" pm="."><plain>Deletions of 298 amino acids in the N-terminus and 9 amino acids in the C-terminus did not affect POMGnT1 activity, while larger deletions on either end abolished activity </plain></SENT>
<SENT sid="4" pm="."><plain>These data indicate that the minimal catalytic domain is at least 353 amino acids </plain></SENT>
<SENT sid="5" pm="."><plain>Single amino acid substitutions in the stem domain of POMGnT1 from MEB patients abolished the activity of the membrane-bound form but not the soluble form </plain></SENT>
<SENT sid="6" pm="."><plain>This suggests that the stem domain of the soluble form of POMGnT1 is unnecessary for activity, but that some amino acids play a crucial role in the membrane-bound form </plain></SENT>
</text></document>